Shanghai Henlius Biotech, Inc. (“Henlius”) announced FDA acceptance of the Biologics License Application (BLA) for ...
In addition to the UK investment controversy, AstraZeneca is also dealing with legal challenges in China. The company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback